AEON Biopharma, Inc. — Form D

AEON Biopharma, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-11. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Simone BlankDirectorIrvine, CA
Jost FischerDirectorIrvine, CA
Robert GrantDirectorSonoma, CA
Vikram MalikDirectorIrvine, CA
Darren O'BrienDirectorIrvine, CA
Richard TaketaDirectorIrvine, CA
Chris CarrExecutive OfficerIrvine, CA
Marc ForthExecutive OfficerIrvine, CA
Chad OhExecutive OfficerIrvine, CA
Alex WilsonExecutive OfficerMiami, FL
ROBERT E GRANTDirectorNEWPORT BEACH, CA
ROBERT E GRANTExecutive OfficerNEWPORT BEACH, CA
Scott AkamineExecutive OfficerNewport Beach, CA
Hans S KeirsteadDirectorIrvine, CA
Juliet Tammenoms BakkerDirectorIrvine, CA
Craig Tammenoms KussmanExecutive OfficerIrvine, CA
William E LinkDirectorIrvine, CA
William E LinkExecutive OfficerIrvine, CA
Bosun Tammenoms HauDirectorIrvine, CA
Patrick S MaxwellDirectorIrvine, CA
Richard S LindstromDirectorIrvine, CA
Robert S HaymanDirectorIrvine, CA
Robert Tammenoms RhatiganExecutive OfficerIrvine, CA
Dennis Tammenoms WolfDirectorIrvine, CA
Vikram S MalikDirectorIrvine, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2022-08-11D$25.0M$24.5M
2021-05-13D/A$30.0M$30.0M
2020-08-31D$25.0M$25.0M
2016-08-10D$55.0M$5.5M
2015-11-20D$150.0M$80.1M
2015-01-22D$40.5M$27.0M

More